Increased visceral adiposity is typically associated with insulin resistance and other features of the metabolic syndrome (Tran et al., 2008); therefore, the apparent uncoupling of visceral adiposity and insulin resistance seen with T-bet deficiency, even in young mice, was both unusual and unexpected. Here, TBX21 is linked to metabolic syndrome.